There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immatics (IMTX) and Star Equity Holdings (STRR) with bullish sentiments.
Immatics (IMTX)
In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Immatics, with a price target of $30.00. The company’s shares closed last Tuesday at $11.01.
According to TipRanks.com, Livshits is a top 100 analyst with an average return of 61.2% and a 59.9% success rate. Livshits covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Iovance Biotherapeutics, and Adverum Biotechnologies.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Immatics with a $25.00 average price target.
See today’s analyst top recommended stocks >>
Star Equity Holdings (STRR)
Maxim Group analyst Tate Sullivan maintained a Buy rating on Star Equity Holdings yesterday and set a price target of $5.50. The company’s shares closed last Tuesday at $2.60.
According to TipRanks.com, Sullivan is a 5-star analyst with an average return of 21.7% and a 51.6% success rate. Sullivan covers the Industrial Goods sector, focusing on stocks such as Natural Gas Services Group, Ceco Environmental, and Mistras Group.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Star Equity Holdings with a $5.50 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
